Editors' Note: Effect of Immunosuppression in Risk of Developing Generalized Symptoms in Ocular Myasthenia Gravis: A Retrospective Cohort Study. Siegler JE, Galetta SL. Neurology 2025;105:e213926.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Siegler JE, Galetta SL. Editors' Note: Effect of Immunosuppression in Risk of Developing Generalized Symptoms in Ocular Myasthenia Gravis: A Retrospective Cohort Study. Neurology 2025;105:e213926.
PMID: 40680253